Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 29

    1.

    Clinical applications of rituximab in allogeneic stem cell transplantation: Anti-tumor and immunomodulatory effects.

    Ratanatharathorn V, Pavletic S, Uberti JP.

    Cancer Treat Rev. 2009 Dec;35(8):653-61. Epub 2009 Aug 13.PMID: 19682801 [PubMed - in process]Related articles

    2.

    Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.

    Martin PJ, Bachier CR, Klingemann HG, McCarthy PL, Szabolcs P, Uberti JP, Schuster MW, Weisdorf D, Chao NJ, Kebriaei P, Shpall EJ, Macmillan ML, Soiffer RJ.

    Biol Blood Marrow Transplant. 2009 Jul;15(7):777-84. Epub 2009 May 13. Review.PMID: 19539208 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.

    Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti JP, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaüser M, Hale G, Verdonck L, Cairo M, Gupta V, Pavletic S; Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.

    Br J Haematol. 2009 Jun;145(6):816-24. Epub 2009 Mar 26.PMID: 19344418 [PubMed - indexed for MEDLINE]Related articles

    4.

    Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease.

    Ibrahim RB, Abidi MH, Cronin SM, Lum LG, Al-Kadhimi Z, Ratanatharathorn V, Uberti JP.

    Biol Blood Marrow Transplant. 2009 Apr;15(4):395-405. Epub 2009 Feb 10. Review.PMID: 19285626 [PubMed - indexed for MEDLINE]Related articles

    5.

    Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.

    Karanes C, Nelson GO, Chitphakdithai P, Agura E, Ballen KK, Bolan CD, Porter DL, Uberti JP, King RJ, Confer DL.

    Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):8-15. Review.PMID: 18721775 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem cell transplantation.

    Ibrahim RB, Abidi MH, Ayash LJ, Cronin SM, Cadotte C, Mulawa J, Jacobson PA, Smith DW, Uberti JP, Edwards DJ.

    J Oncol Pharm Pract. 2008 Sep;14(3):113-21. Epub 2008 Jun 13. Erratum in: J Oncol Pharm Pract. 2008 Dec;14(4):233. PMID: 18556719 [PubMed - indexed for MEDLINE]Related articles

    7.

    Optimum use of tacrolimus in the prophylaxis of graft versus host disease.

    Uberti JP, Cronin S, Ratanatharathorn V.

    BioDrugs. 1999 May;11(5):343-58.PMID: 18031144 [PubMed - in process]Related articles

    8.

    Bronchiolitis obliterans following haematopoietic stem cell transplantation.

    Soubani AO, Uberti JP.

    Eur Respir J. 2007 May;29(5):1007-19. Review.PMID: 17470622 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.

    Ayash LJ, Ratanatharathorn V, Braun T, Silver SM, Reynolds CM, Uberti JP.

    Am J Hematol. 2007 Jan;82(1):6-14.PMID: 16986128 [PubMed - indexed for MEDLINE]Related articles

    10.

    Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

    Reddy P, Johnson K, Uberti JP, Reynolds C, Silver S, Ayash L, Braun TM, Ratanatharathorn V.

    Bone Marrow Transplant. 2006 Sep;38(5):351-7. Epub 2006 Jul 24.PMID: 16862167 [PubMed - indexed for MEDLINE]Related articles

    11.

    Do negative or positive emotions differentially impact mortality after adult stem cell transplant?

    Hoodin F, Uberti JP, Lynch TJ, Steele P, Ratanatharathorn V.

    Bone Marrow Transplant. 2006 Aug;38(4):255-64. Epub 2006 Jun 19. Review.PMID: 16785869 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.

    Uberti JP, Ayash L, Ratanatharathorn V, Silver S, Reynolds C, Becker M, Reddy P, Cooke KR, Yanik G, Whitfield J, Jones D, Hutchinson R, Braun T, Ferrara JL, Levine JE.

    Biol Blood Marrow Transplant. 2005 Sep;11(9):680-7.PMID: 16125638 [PubMed - indexed for MEDLINE]Related articles

    13.

    Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.

    Uberti JP, Ayash L, Braun T, Reynolds C, Silver S, Ratanatharathorn V.

    Bone Marrow Transplant. 2004 Sep;34(5):425-31.PMID: 15273705 [PubMed - indexed for MEDLINE]Related articles

    14.

    Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.

    Dawson LA, Saito NG, Ratanatharathorn V, Uberti JP, Adams PT, Ayash LJ, Reynolds CM, Silver SM, Schipper MJ, Lichter AS, Eisbruch A.

    Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):208-18.PMID: 15093918 [PubMed - indexed for MEDLINE]Related articles

    15.

    West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation.

    Reddy P, Davenport R, Ratanatharathorn V, Reynolds C, Silver S, Ayash L, Ferrara JL, Uberti JP.

    Bone Marrow Transplant. 2004 Jan;33(1):109-12.PMID: 14566328 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.

    Ratanatharathorn V, Ayash L, Reynolds C, Silver S, Reddy P, Becker M, Ferrara JL, Uberti JP.

    Biol Blood Marrow Transplant. 2003 Aug;9(8):505-11.PMID: 12931119 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.

    Levine JE, Uberti JP, Ayash L, Reynolds C, Ferrara JL, Silver SM, Braun T, Yanik G, Hutchinson R, Ratanatharathorn V.

    Biol Blood Marrow Transplant. 2003 Mar;9(3):189-97.PMID: 12652470 [PubMed - indexed for MEDLINE]Related articles

    18.

    Chronic graft-versus-host disease: clinical manifestation and therapy.

    Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP.

    Bone Marrow Transplant. 2001 Jul;28(2):121-9. Review.PMID: 11509929 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.

    Cronin S, Uberti JP, Ayash LJ, Raith C, Ratanatharathorn V.

    Bone Marrow Transplant. 2000 Dec;26(11):1247-9.PMID: 11149742 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease.

    Ratanatharathorn V, Carson E, Reynolds C, Ayash LJ, Levine J, Yanik G, Silver SM, Ferrara JL, Uberti JP.

    Ann Intern Med. 2000 Aug 15;133(4):275-9.PMID: 10929168 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies.

    Uberti JP, Silver SM, Adams PT, Jacobson P, Scalzo A, Ratanatharathorn V.

    Bone Marrow Transplant. 1997 Jun;19(12):1233-8.PMID: 9208118 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Clinical course and outcome of patients with Hodgkin's disease who progress after autologous transplantation.

    Varterasian M, Ratanatharathorn V, Uberti JP, Karanes C, Abella E, Momin F, Kasten-Sportes C, Al-Katib A, Lum L, Heilbrun LK, et al.

    Leuk Lymphoma. 1995 Dec;20(1-2):59-65.PMID: 8750624 [PubMed - indexed for MEDLINE]Related articles

    23.

    Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation.

    Turkeri LN, Lum LG, Uberti JP, Abella E, Momin F, Karanes C, Sensenbrenner LL, Haas GP.

    J Urol. 1995 Mar;153(3 Pt 1):637-40.PMID: 7861502 [PubMed - indexed for MEDLINE]Related articles

    24.

    Allogeneic bone marrow transplantation in patients with myelodysplastic syndromes.

    Uberti JP, Ratanatharathorn V, Karanes C, Sensenbrenner LL.

    Leuk Lymphoma. 1994 Aug;14(5-6):379-85. Review.PMID: 7812196 [PubMed - indexed for MEDLINE]Related articles

    25.

    Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.

    Schultz KR, Ratanatharathorn V, Abella E, Eisenbrey AB, Karanes C, Lum LG, de Planque MM, Uberti JP, Ravindranath Y, Sensenbrenner LL.

    Bone Marrow Transplant. 1994 Jun;13(6):817-22.PMID: 7920320 [PubMed - indexed for MEDLINE]Related articles

    26.

    Preclinical studies using immobilized OKT3 to activate human T cells for adoptive immunotherapy: optimal conditions for the proliferation and induction of non-MHC-restricted cytotoxicity.

    Uberti JP, Joshi I, Ueda M, Martilotti F, Sensenbrenner LL, Lum LG.

    Clin Immunol Immunopathol. 1994 Mar;70(3):234-40.PMID: 8313660 [PubMed - indexed for MEDLINE]Related articles

    27.

    Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.

    Lum LG, Joshi ID, Smith MR, Ratanatharathorn V, Galoforo SC, Karanes C, Uberti JP, Sensenbrenner LL.

    Bone Marrow Transplant. 1994 Feb;13(2):187-95.PMID: 8205088 [PubMed - indexed for MEDLINE]Related articles

    28.

    Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.

    Lum LG, Joshi ID, Galoforo SC, Abella E, Karanes C, Ratanatharathorn V, Schultz KR, Uberti JP, Sensenbrenner LL, Ledbetter JA, et al.

    Bone Marrow Transplant. 1993 Dec;12(6):565-71.PMID: 8136739 [PubMed - indexed for MEDLINE]Related articles

    29.

    Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.

    Ueda M, Joshi ID, Dan M, Uberti JP, Chou TH, Sensenbrenner LL, Lum LG.

    Transplantation. 1993 Aug;56(2):351-6.PMID: 8356589 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...